FDA publishes new Financial Disclosure Guidelines

New Financial Disclosure Guidelines from FDA (Orthopedics This Week) If you own shares in a mutual fund that includes a company for whom you are a clinical investigator for an FDA-sponsored investigation, do you have to disclose that? Can a literature report be considered a covered clinical study? The FDA’s got the answers for you in a new guidance. The “Guidance for Clinical Investigators, Industry, and FDA Staff – Financial Disclosure by Clinical Investigators,” was issued in February and is a revision of 2001 guidance. Applicants who submit a marketing application for a drug, biological pro...


Unlock the full article and exclusive OrthoStreams insights: in-depth analyses, hot startups, trends, market intel, and Daily Newsletter—for just $1/day.
Subscribe Now—Up your Game !
 

Scroll to Top